Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-29
REV
Q1 2021Est.ActualSurprise
EPS-0.080-0.310 -0.2300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DSGNDesign Therapeutics17.61%

Design Therapeutics Frequently Asked Questions

Q

How do I buy Design Therapeutics (DSGN) stock?

A

You can purchase shares of Design Therapeutics (NASDAQ: DSGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Design Therapeutics's (DSGN) competitors?

A

There are no as such competitors for Design Therapeutics.

Q

What is the target price for Design Therapeutics (DSGN) stock?

A

The latest price target for Design Therapeutics (NASDAQ: DSGN) was reported by SVB Leerink on April 20, 2021. The analyst firm set a price target for 36.00 expecting DSGN to rise to within 12 months (a possible 54.97% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Design Therapeutics (DSGN)?

A

The stock price for Design Therapeutics (NASDAQ: DSGN) is $23.23 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Design Therapeutics (DSGN) pay a dividend?

A

There are no upcoming dividends for Design Therapeutics.

Q

When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?

A
Design Therapeutics’s Q2 earnings are confirmed for after-market on July 29, 2021.
Q

Is Design Therapeutics (DSGN) going to split?

A

There is no upcoming split for Design Therapeutics.

Q

What sector and industry does Design Therapeutics (DSGN) operate in?

A

Design Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.